Table 1. Baseline characteristics of study participants by group.
| Standard group (n = 250) | Same-day treatment group (n = 250) | |
|---|---|---|
| Female—no. (%) | 117 (46·8) | 117 (46·8) |
| Age at enrollment (years)—median (IQR) | 37·0 (30·0, 45·0) | 36·0 (30·0, 45·0) |
| Income—no. (%) | ||
| <$US 1.00 per day | 190 (76·0) | 182 (72·8) |
| ≥$US 1.00 per day | 58 (23·2) | 65 (26·0) |
| Missing or unknown | 2 (0·8) | 3 (1·2) |
| Education level—no. (%) | ||
| None | 46 (18·4) | 38 (15·2) |
| Some primary | 95 (38·0) | 101 (40·4) |
| At least some secondary | 107 (42·8) | 107 (42·8) |
| Missing or unknown | 2 (0·8) | 4 (1·6) |
| Marital status—no. (%) | ||
| Single | 64 (25·6) | 70 (28·0) |
| Married | 137 (54·8) | 124 (49·6) |
| Formerly married | 47 (18·8) | 53 (21·2) |
| Missing or unknown | 2 (0·8) | 3 (1·2) |
| TB symptoms—no. (%) | ||
| Reported cough | 100 (40·0) | 100 (40·0) |
| Reported fever | 96 (38·4) | 98 (39·2) |
| Reported night sweats | 34 (13·6) | 38 (15·2) |
| Reported weight loss | 243 (97·2) | 248 (99·2) |
| BMI—median (IQR) | 21·0 (18·8, 23·5) | 20·3 (18·5, 22·7) |
| CD4 count (cells/mm3)—median (IQR) | 293 (157, 447) | 228 (114, 398) |
| CD4 count category—no. (%) | ||
| <100 cells/mm3 | 43 (17·2) | 58 (23·2) |
| 100 to 349 cells/mm3 | 109 (43·6) | 116 (46·4) |
| 350 to 499 cells/mm3 | 48 (19·2) | 36 (14·4) |
| ≥500 cells/mm3 | 47 (18·8) | 38 (15·2) |
| Missing | 3 (0·6) | 2 (0·4) |
| Hemoglobin (g/dl)—median (IQR) | 12·0 (10·2, 13·6) | 11·7 (10·0, 13·4) |
| TB status at HIV diagnosis—no. (%) | ||
| Bacteriologically confirmed TB | 32 (12·8) | 36 (14·4) |
| Empirically diagnosed TB | 8 (3·2) | 12 (4·8) |
| TB not diagnosed | 210 (84·0) | 202 (80·8) |
BMI, body mass index; IQR, interquartile range; TB, tuberculosis.